Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

News Article

Virally vectored ASFV antigens protect pigs from developing severe disease


Study provides the basis for the development of a subunit vaccine against African swine fever

Researchers at The Pirbright Institute have developed a vectored vaccine, which uses a non-harmful virus (adenovirus prime and modified vaccinia Ankara boost) to deliver eight strategically selected genes from the African swine fever virus (ASFV) genome into pig cells. Once inside the cell, the genes produce viral proteins which primes the pig immune cells to respond to an ASF infection. All pigs that were immunised with the vaccine were protected from severe disease after challenge with an otherwise fatal strain of ASFV, although some clinical signs of disease did develop. The study is published in Vaccines.

Dr Chris Netherton, Head of Pirbright’s ASF Vaccinology Group, said: “It is very encouraging to see that the genes we have selected are able to protect pigs against ASF. Although the pigs showed clinical signs of infection after challenge with the virus, our study has shown for the first time that a vectored vaccine against ASF is a realistic possibility.”

This type of vaccine will also enable the differentiation of infected animals from those that have received a vaccine (DIVA). This is an important feature, as it allows vaccination programmes to be established without sacrificing the ability to trade.

“Our next step will be to uncover the mechanisms behind how the proteins produced by the virus genes stimulate the immune system so we can refine and add to those included in the vaccine to improve effectiveness” added Dr Netherton.

Article: Goatley, L.C.; Reis, A.L.; Portugal, R.; Goldswain, H.; Shimmon, G.L.; Hargreaves, Z.; Ho, C.-S.; Montoya, M.; Sánchez-Cordón, P.J.; Taylor, G.; Dixon, L.K.; Netherton, C.L. (2020). A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs Against Fatal Disease. Vaccines, 8(2), 234, doi: 10.3390/vaccines8020234

Article details

  • Date
  • 22 May 2020
  • Source
  • The Pirbright Institute
  • Subject(s)
  • Food Animals